AKT1 and ovarian cancer: The FASN inhibitor TVB-3166 can destroy the lipid structure on membrane of cancer cell, inhibit lipid biosynthesis, and promote cancer cell apoptosis through the PI3K-AKT-mTOR and β-catenin signaling pathways in ovarian cancer.